DexCom, Inc. Stock News

DexCom, Inc. (NASDAQ:DXCM ) 2025 Wells Fargo Healthcare Conference September 3, 2025 2:15 PM EDT Company Participants Jacob Leach - President & COO Jereme Sylvain - Executive VP, CFO & Chief Accounting Officer Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Welome back. I am ...

Shares of DexCom (DXCM 0.02%), a medical device specialist, have lagged the market this year. However, the true test of a company isn't how it performs over a relatively short period, such as eight months.

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: The 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025 at 2:15 pm (EDT) The Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 2:00 pm (EDT) Links to the webcast will be available...

Despite President Donald Trump's trade wars and concerns about a possible recession, equity markets have performed relatively well this year, with the S&P 500 (^GSPC -0.29%) up 10% since January. Some corporations, however, have not been as fortunate, including PayPal (PYPL -0.20%) and DexCom (DXCM 1.23%), both of which have underperformed the market due to company-specific issues.

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DexCom, Inc. (NASDAQ: DXCM) on behalf of long-term stockholders following a class action complaint that was filed against DexCom on August 21, 2024 with a Class Period from January 8, 2024 to July 25, 2024. Our investigation conc...

DexCom (DXCM) Q2 Revenue Jumps 15%

DexCom, Inc. (NASDAQ:DXCM ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Jacob Steven Leach - President & COO Jereme M. Sylvain - Executive VP, CFO & Chief Accounting Officer Kevin Ronald Sayer - Executive Chairman & CEO Sean Christensen - Vice President of Finance and Investor Relations Conference Call Participants Brandon Vazquez - William Blair & Company L.L.C.

Dexcom beat estimates for second-quarter results on Wednesday, driven by strong demand for its continuous glucose monitors, and named Jake Leach as its CEO.